AI helps with schizophrenia diagnosis, research shows
Artificial intelligence and machine learning algorithms can help diagnose schizophrenia more quickly and accurately, according to research by the University of Alberta and IBM scientists.
The research, published in May’s npj Schizophrenia, with University of Alberta post-doctoral researcher Mina Gheiratmand as the primary author, was able to predict instances of schizophrenia with 74 per cent accuracy.
The team, working out of the IBM Alberta Centre for Advanced Studies, also discovered the ability to predict the severity of specific symptoms in schizophrenia patients — something that wasn’t possible before.
Schizophrenia doesn’t currently have medical testing that can provide an absolute diagnosis, which can cause a significant delay before a symptomatic person is properly diagnosed.
The chronic neurological disorder affects seven or eight of every 1,000 people and those with the disorder can experience hallucinations, movement disorders and cognitive impairments.
These findings can be used to help doctors more quickly assess and begin treatment for patients, as well as measure the progression of the disorder and the effectiveness of treatment, Gheiratmand said.
For the study, researchers analyzed brain functional magnetic resonance imaging (fMRI) data — which Gheiratmand explained is basically a movie of the brain while it’s in action — of patients with schizophrenia, as well as a healthy control group without the disorder.
The team used machine learning techniques to examine brain scans of the 95 participants to develop a model of schizophrenia that identifies the connections in the brain most associated with the disorder.
Further, the research showed a similar model can be used to determine the severity of symptoms, including inattentiveness, formal thought disorder and lack of motivation.
This discovery could lead to a “spectrum” characterization of schizophrenia and not just a binary label of simply having it or not.
“It actually enables us to give a more precise, more measurementbased characterization of the disease,” Gheiratmand said.